Aspira Women's Health Inc. (AWHL)

Aspira Women's Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16	12	42	41	198	698
Market Cap Growth	205.89%	-72.14%	1.77%	-79.12%	-71.58%	786.73%
Enterprise Value	15	12	39	24	157	682
Last Close Price	0.36	0.70	4.08	4.99	26.55	100.65
PS Ratio	1.70	1.28	4.61	5.06	29.13	150.17
PB Ratio	-3.65	-4.58	-17.83	5.94	6.58	71.86
P/TBV Ratio	-	-	-	5.94	6.58	71.86
EV/Sales Ratio	1.57	1.28	4.31	2.94	23.05	146.67
Debt / Equity Ratio	-0.59	-1.32	-1.21	0.55	0.14	0.53
Net Debt / Equity Ratio	0.28	-0.63	-0.11	-1.36	-1.10	-1.18
Net Debt / EBITDA Ratio	0.12	-0.10	-0.01	0.31	1.02	0.66
Net Debt / FCF Ratio	0.20	-0.13	-0.02	0.30	1.20	0.75
Asset Turnover	1.55	1.56	0.78	0.28	0.23	0.28
Inventory Turnover	11.79	13.39	14.34	15.76	36.77	115.09
Quick Ratio	1.22	0.51	0.79	2.63	4.87	2.92
Current Ratio	1.39	0.77	1.03	2.95	5.10	3.10
Return on Equity (ROE)	-	-	-723.45%	-160.88%	-158.74%	-194.02%
Return on Assets (ROA)	-104.31%	-173.13%	-99.70%	-66.59%	-67.14%	-66.29%
Return on Capital Employed (ROCE)	-324.80%	-70773.90%	-1649.30%	-262.90%	-98.10%	-130.30%
Earnings Yield	-68.11%	-111.43%	-39.57%	-72.12%	-15.95%	-2.56%
FCF Yield	-38.33%	-103.40%	-37.74%	-75.53%	-13.90%	-2.18%
Buyback Yield / Dilution	-119.68%	-53.08%	-18.85%	-4.79%	-10.41%	-16.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.